Navigation Links
Kiwa Bio-Tech Ships 2,700 Tons of Bio-feed in One Month
Date:10/2/2007

BEIJING and CLAREMONT, Calif., Oct. 2 /PRNewswire-FirstCall/ -- Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) today announced that the Tianjin Kiwa Feed Limited Liability Company, located in Wuqing District in Tianjin, shipped 2,700 tons of animal feed during the month of September.

Mr. Wei Li, Chairman and CEO of Kiwa, stated, "We are pleased with the growth in volume of Kiwa's bio-feed products to approximately 7,550 tons during the third quarter compared to approximately 5,000 for the first two quarters of the year. We anticipate continued growth of the feed products will be complemented by sales of organic fertilizers from the Shandong factory."

Kiwa recently announced that:

-- it had completed the first stage of upgrading the manufacturing

facility for its fertilizer products,

-- had registered products with the Shandong Provincial Soil and

Fertilizer Station and

-- had six products certified as organic by the China Green Food

Association of the Agriculture Ministry

Tianjin Kiwa Feed is jointly owned by Kiwa and Tianjin Challenge Feed Co. Tianjin Challenge Feed Co. is partially owned by and has built a large sales network, in part, due to its relations with China Challenge Group. Its products are sold in Shandong, North China and Northeast China.

About Kiwa Bio-Tech Products Group Corporation

The Company develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. For more information about the Company, please visit the Company's website at http://www.kiwabiotech.com.

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

Contact:

Kiwa Bio-Tech Products Group Corporation

Yvonne Wang

(626) 715-5855

kiwabiotech@gmail.com

Robert Schechter

Equity Communications

212-499-6809 direct 646 234 3624

ir4kiwa@hotmail.com


'/>"/>
SOURCE Kiwa Bio-Tech Products Group Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Industry Veterans take a look back from 2025: Bio-Technology, and Bio-Informatics are the focus
2. Big pharma seeks Wisconsin biotech partnerships
3. Dont forget building relationships when building business
4. 40 Midwest biotech organizations to explore Japanese partnerships
5. Meriter IT team builds project performance through internal relationships
6. Blooming partnerships
7. Enhancing Relationships with Investors
8. Avoid Trading Tech Relationships Like Pokmon Cards
9. Quantity versus Quality: Effective E-Marketing Relationships
10. EraGen Biosciences Ships SARS Diagnostic Test in Record Time
11. Milwaukee could be wireless in 18 months
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and ... of osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular ...
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... ... ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... event entitled “Stem Cells and Their Regenerative Powers,” was held on August 31st, ... was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic Surgery, ...
(Date:10/10/2017)... 2017 SomaGenics announced the receipt of a ... RealSeq®-SC (Single Cell), expected to be the first commercially ... microRNAs) from single cells using NGS methods. The NIH,s ... accelerate development of approaches to analyze the heterogeneity of ... techniques for measuring levels of mRNAs in individual cells ...
Breaking Biology Technology:
(Date:4/4/2017)... 2017   EyeLock LLC , a leader of ... States Patent and Trademark Office (USPTO) has issued U.S. ... of an iris image with a face image acquired ... company,s 45 th issued patent. ... given the multi-modal biometric capabilities that have recently come ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
Breaking Biology News(10 mins):